Laboratories, Inc., Minnetonka, MN, USA) and the hemagglutinin titer was checked at days 6 and 10.
A modifi ed case defi nition for pandemic (H1N1) 2009 infection was developed based on Canada's surveillance case defi nition for infl uenza-like illness. Symptom onset was defi ned as earliest date of onset of self-reported history of fever or cough. The case defi nition is outlined in Table 1 .
During August 3-27, 2009, we conducted 144 faceto-face and 21 phone interviews. Approximately 20% of cadets and 20% of staff cadets, offi cers, and support staff participated. Of the 165 participants, 56 were classifi ed as confi rmed cases, 24 as suspected cases, and 85 as controls. Participant age ranged from 13 to 43 years; 88% were 13-18 years of age, and 55% were male. No statistically signifi cant demographic differences (p<0.05) were observed between confi rmed cases, suspected cases, or controls.
The epidemic curve ( Figure) summarizes the outbreak among those with known symptom onset date for cases (n = 54), suspected cases (n = 21), and 27 additional cases of fever and cough identifi ed by the camp Health Care Centre (HCC) but not included in the study. The minimum camp attack rate for cases/suspected cases and HCC cases not in the study was 13.5% (112/828), 14.0% among cadets (71/506) and 12.7% among staff cadets and offi cers (41/322).
The outbreak was identifi ed on July 17. In response, respiratory etiquette and hand hygiene were emphasized; camp residents were encouraged to seek care if ill. Those having fever and cough were isolated for 7 days, until parents came, or until laboratory results returned negative. Group outdoor activities stopped on July 23; all group activities were cancelled as of July 25. Some cadets were fast-tracked to graduate early, and arrival of new cadets was delayed 2 weeks. Mass screening for fever and cough was undertaken on August 6, before the arrival of new cadets; all the new cadets were screened on arrival.
No activity or exposure was linked to increased risk for illness (data not shown). All but 1 person with a suspected or confi rmed case reported symptoms; 58/85 (68.2%) of controls also reported symptoms during the outbreak period. Odds of experiencing shortness of breath, chest pain, sputum production, vomiting, rhinorrhea, nose bleeds, or change in level of awareness were all >5× higher for those with cases/suspected cases than for controls ( Table 2 ). The mean number of symptoms among those with symptomatic cases/suspected cases was greater than among symptomatic controls (8.7 vs. 3.4; p<0.001). This relationship held true when comparing those with cases/suspected cases with symptomatic controls who had negative PCR results.
Of the 78 persons with symptomatic/suspected cases for whom complete information was available, 25 (32.1%) had recovered by the interview; median symptom duration was 7 and 9 days, respectively. Symptom duration >10 days was reported by 40% of persons with cases/suspected cases whose symptoms had resolved and 47% of those with unresolved symptoms. Median time from symptom onset to illness peak was 2 days (range 1-14 days). With the exception of cough, sputum production, and malaise, symptoms peaked rapidly (24-48 hours) after onset.
Overall, 86.1% of persons with cases/suspected cases accessed the HCC; none were hospitalized. Oseltamivir was given to 2 persons with confi rmed cases who had comorbid conditions (asthma and kidney disease). Forty-four persons with cases/suspected cases (55.7%) were not isolated because they did not seek treatment at the HCC or not while both fever and cough were present.
Eight persons had positive PCR results for pandemic (H1N1) 2009 7-18 days after symptom onset, and live virus was detected up to 14 days after symptom onset. All but 1 of these persons were capable of transmitting virus given upper respiratory symptoms, and 2 reported diarrhea and vomiting on the day the swab sample was obtained. Four persons had live virus detected after day 7 of illness (up to 14 days); 2 of these reported comorbid conditions.
Persons with confi rmed and suspected cases did not differ with regard to comorbidity or risk factors, except for seasonal infl uenza vaccination; 6/48 (12.5%) of persons with confi rmed cases reported having received the seasonal infl uenza vaccine in the year of the study versus 8/22 (36.4%) of those with suspected cases (odds ratio 4.0; p<0.05). No difference was found in the proportion of those with cases/suspected cases and controls reporting seasonal infl uenza vaccination during the current year or past 2 years.
The odds of reporting >1 comorbidity was >2.7× higher for persons with case/suspected cases than for controls (p<0.05) and for asthma >3.9× higher (p < 0.05). The odds of being obese were >3× higher for persons with cases/ suspected cases (odds ratio 3.4, 95% confi dence interval 1.0-10.9).
Conclusions
In accordance with national recommendations (2), antiviral drugs were not used for control; transmission appeared to be reduced through nonpharmaceutical measures. Multiple index cases could not be ruled out. No individual activity or exposure was linked to increased risk for illness.
High rates of obesity have been noted among hospitalized patients with pandemic (H1N1) 2009 (3-6). This study suggests obesity is a risk factor for infection or clinical illness and given low prevalence of comorbid conditions may stand alone as a risk factor. Consistent with international studies (7), vaccination for seasonal infl uenza was neither protective nor a risk factor for acquiring pandemic (H1N1) 2009. One third of case-patients reported change in level of awareness, which suggests the potential for mild neurologic sequelae. Neurologic complications of infl uenza infection have been reported in hospitalized children (8, 9) .
Seven of 8 participants who had positive PCR results for pandemic (H1N1) 2009 >7 days after symptom onset were capable of transmitting virus, given their upper respiratory symptoms on the day the swab sample was obtained. Studies of seasonal infl uenza indicate median viral shedding of 7-8 days after illness onset, with titers low or undetectable by day 5, although prolonged shedding has been reported (10) (11) (12) (13) . In this study, test results for pandemic (H1N1) 2009 were positive by culture up to 14 days and by PCR up to 18 days after symptom onset. This and other studies describe longer shedding periods for pandemic (H1N1) 2009 as compared with seasonal infl uenza (10, (13) (14) (15) .
Study limitations should be acknowledged. The case defi nition included self-reported fever and cough. Therefore, misclassifi cation of persons with illnesses other than pandemic (H1N1) 2009 may have occurred. Convenience sampling was used, so participants may differ from nonparticipants; complete demographics for the camp were not available for comparison. A small proportion of phone interviews were conducted <6 weeks after symptom onset, raising the possibility of recall bias.
Infection control procedures likely contributed to the control of transmission in the absence of antiviral drug use or early treatment for contacts. Shedding in otherwise healthy adolescents and young adults may be longer than shedding of seasonal infl uenza viruses, which may have implications for public health planning. *One person reported no symptoms but was PCR and culture positive. OR, odds ratio; CI, confidence interval; NA, not applicable. †Fever and nausea reported by a greater proportion of cases than suspected cases (p<0.001 and p = 0.02, respectively). Cases and suspected cases did not differ significantly in frequency of symptoms not in the case definition or median number of symptoms and have therefore been combined here. ‡Odds ratios were not calculated for symptoms included in the case definition (fever, chills, cough, sore throat, congestion, nausea). §p<0.01. ¶p<0.001. #p<0.05. **Other symptoms reported: bilateral ear infection, bruising, ear pain, ear popping, eye pain, hot flashes, jaw pain, loss of appetite, loss of voice, rib pain, swelling of eyes, swollen tonsils, toothache (1 person each); dizziness (3 persons). All persons who reported symptoms in this category had >1 other reported symptom.
